Hypothyroidism as Prognostic Factor in Cutaneous Melanoma: A 1553‐Patient Single‐Center Study

Our findings suggest that hypothyroidism is markedly more prevalent among patients with cutaneous melanoma and may be associated with clinical features linked to improved prognosis. These observations warrant further investigation to clarify whether hypothyroidism itself, or its underlying immunologic and hormonal milieu, plays a protective role in melanoma progression.